 Phentermine
"Phentermine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.
| Descriptor ID |
D010645
|
| MeSH Number(s) |
D02.092.471.683.152.766
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Phentermine".
Below are MeSH descriptors whose meaning is more specific than "Phentermine".
This graph shows the total number of publications written about "Phentermine" by people in this website by year, and whether "Phentermine" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 | | 2004 | 0 | 1 | 1 | | 2013 | 1 | 0 | 1 | | 2016 | 1 | 1 | 2 | | 2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Phentermine" by people in Profiles.
-
Lewis KH, Fischer H, Ard J, Bessesen D, Daley M, Desai J, Fitzpatrick S, Horberg M, Koebnick C, Oshiro C, Young DR, Arterburn DE. Response to "Knowledge Gaps in Long-Term Phentermine Use". Obesity (Silver Spring). 2019 08; 27(8):1220.
-
Lewis KH, Fischer H, Ard J, Barton L, Bessesen DH, Daley MF, Desai J, Fitzpatrick SL, Horberg M, Koebnick C, Oshiro C, Yamamoto A, Young DR, Arterburn DE. Safety and Effectiveness of Longer-Term Phentermine Use: Clinical Outcomes from an Electronic Health Record Cohort. Obesity (Silver Spring). 2019 04; 27(4):591-602.
-
Ryder JR, Kaizer A, Rudser KD, Gross A, Kelly AS, Fox CK. Effect of phentermine on weight reduction in a pediatric weight management clinic. Int J Obes (Lond). 2017 01; 41(1):90-93.
-
Nuffer W, Trujillo JM, Megyeri J. A Comparison of New Pharmacological Agents for the Treatment of Obesity. Ann Pharmacother. 2016 May; 50(5):376-88.
-
Thomas EA, Mcnair B, Bechtell JL, Ferland A, Cornier MA, Eckel RH. Greater hunger and less restraint predict weight loss success with phentermine treatment. Obesity (Silver Spring). 2016 Jan; 24(1):37-43.
-
Hendricks EJ, Srisurapanont M, Schmidt SL, Haggard M, Souter S, Mitchell CL, De Marco DG, Hendricks MJ, Istratiy Y, Greenway FL. Addiction potential of phentermine prescribed during long-term treatment of obesity. Int J Obes (Lond). 2014 Feb; 38(2):292-8.
-
Smith SM, Meyer M, Trinkley KE. Phentermine/topiramate for the treatment of obesity. Ann Pharmacother. 2013 Mar; 47(3):340-9.
-
Hiatt WR, Thomas A, Goldfine AB. What cost weight loss? Circulation. 2012 Mar 06; 125(9):1171-7.
-
Horton MR, Tuder RM. Primary pulmonary arterial hypertension presenting as diffuse micronodules on CT. Crit Rev Comput Tomogr. 2004; 45(5-6):335-41.
-
Kimmel SE, Keane MG, Crary JL, Jones J, Kinman JL, Beare J, Sammel M, Sutton MS, Strom BL. Detailed examination of fenfluramine-phentermine users with valve abnormalities identified in Fargo, North Dakota. Am J Cardiol. 1999 Aug 01; 84(3):304-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|